Pay in 4 interest-free payments of $5.65 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Its pathway to NHS availability will depend on the successful completion of Phase 3 TRIUMPH trials, followed by a marketing authorisation application to the MHRA (the UK's independent medicines regulator) and potentially the EMA for European markets
By engaging the HGF pathway, Dihexa is studied for whether it can support the structural framework the brain uses to store and retrieve information
PubMed laboratory research record [PMID: 19056606] PubMed record related to this compound for laboratory literature review
Guinovart M, Coronas R, Caixas A
Le principe actif smaglutide est un agoniste du GLP-1 (glucagon-like peptide-1), une hormone intestinale qui aide rguler la glycmie et la sensation de faim
US$ 26.58
US$ 20.46
US$ 20.38
US$ 25.59
US$ 22.93
